Tablet Supplements Manufacturing by CSK Biotech

CSK Biotech combines high-capacity production, rigorous quality systems and full-service product development to deliver tablet supplements that meet global market demands. From consumer-ready chewables to advanced controlled-release tablets, our solutions prioritize stability, bioavailability and reliable supply—backed by GMP, FDA, HACCP and ISO certifications and an experienced R&D and regulatory team.

Explore Our High Quality Tablet Solutions

Tablets remain one of the most versatile dosage forms for vitamins, botanicals, nutraceuticals and active nutraceutical blends. They are compact, cost-efficient to produce at scale and familiar to consumers and regulators alike. At CSK Biotech we design tablet formats that solve real-world problems for brand owners: enhanced shelf-life for global distribution, optimized disintegration for better absorption, and tailored sensory profiles for chewables or effervescent systems.

• Immediate-release tablets for rapid nutrient delivery and simple manufacturing workflows.
• Sustained- or controlled-release tablets engineered for prolonged efficacy and competitive differentiation.
• Chewable and flavored tablets for pediatric or convenience-focused markets.
• Layered and multi-ingredient tablets to keep incompatible actives separated until ingestion.
• Coated tablets to improve stability, mask taste and control release characteristics.

Each format is supported by formulation research and pilot runs to verify performance before scale-up, so your finished product meets both consumer expectations and regulatory requirements.

Manufacturing Excellence and Scalable Production

Founded in 2008, CSK Biotech operates a GMP-certified 2,000㎡ facility with seven advanced production lines and annual capacity exceeding 1.5 billion tablets and 4.5 billion softgels. This scale enables competitive unit costs, predictable lead times and rapid ramp-up for seasonal or promotional demand. Our end-to-end CDMO model covers concept development, formulation research, pilot testing, stability verification, production, regulatory registration and marketing support—delivered through three cooperation models:

• ODM: Market-ready formulas and packaging concepts developed by our product innovation team.
• CDM: Tailor-made product design to match specific ingredient profiles and performance targets.
• OEM: Precise, formula-based manufacturing with strict fidelity to your supplied specifications.

Quality control is embedded at every step. Incoming raw materials undergo identity and purity testing, in-process checks ensure tablet weight and content uniformity, and finished-product analyses confirm potency, dissolution and stability. For inquiries, project scoping or to request capability documentation, visit https://www.cskbiotech.com/ or email steve@cskbiotech.com.

Quality, Compliance and Market Support

CSK Biotech is certified by GMPC, FDA, HACCP and ISO, reflecting our commitment to international quality and safety standards. Our regulatory and technical teams support dossier preparation, labeling guidance and export documentation to simplify market entry across regions. We also offer free packaging services and stability studies to validate shelf life under target storage conditions.

Working with CSK means access to experienced formulation scientists, pilot-scale development and a predictable supply chain—so brands can focus on marketing and distribution while we manage product performance, compliance and on-time delivery.

FAQ